These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9007131)

  • 1. Paclitaxel via 1-hour infusion: clinical experience.
    Greco FA; Hainsworth JD
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):91-3. PubMed ID: 9007131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
    Bunn PA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):18-25. PubMed ID: 9007116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-hour paclitaxel in the treatment of non-small cell lung cancer.
    Hainsworth JD; Greco FA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):98-101. PubMed ID: 9007133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel and carboplatin as neoadjuvant chemotherapy in operable (stage I and II) and locally advanced (stage IIIA-N2) non-small cell lung cancer.
    Splinter TA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):59-61. PubMed ID: 9007124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination paclitaxel and platinum in the treatment of lung cancer: US experience.
    Bunn PA
    Semin Oncol; 1996 Dec; 23(6 Suppl 15):9-15. PubMed ID: 8996590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.
    Bunn PA
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-153-S12-162. PubMed ID: 9331142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current role and future prospects of paclitaxel in the treatment of small cell lung cancer.
    Hainsworth JD; Greco FA
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):60-6. PubMed ID: 10190785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer.
    Neill HB; Miller AA; Clamon GH; Perry MC; Crawford J; Green MR
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-130-S12-134. PubMed ID: 9331137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials.
    DeVore RF; Jagasia M; Johnson DH
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-27-S12-29. PubMed ID: 9331116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary results of a dose-finding study of paclitaxel and carboplatin in patients with advanced non-small cell lung cancer.
    Scagliotti GV; Crinó L; Pozzi E; Corgna E; Palladino M; Masiero P; Salsano V; Gentile A; Tonato M
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):80-3. PubMed ID: 9007129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.
    Birch R; Weaver CH; Hainsworth JD; Bobo C; Greco FA
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel (1-hour infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter phase II trial.
    Greco FA; Hainsworth JD
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-14-S12-17. PubMed ID: 9331113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer.
    Choy H; Akerley W; Safran H; Graziano S; Chung C
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):117-9. PubMed ID: 9007137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
    Belani CP
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancer.
    Rosell R; Felip E; Massuti B; González-Larriba JL; Benito D; López-Cabrerizo MP; Salamanca O; Camps C; Puerto-Pica J
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-56-S12-60. PubMed ID: 9331123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel via 1-hour infusion: rationale and pharmacology.
    Greco FA; Hainsworth JD
    Semin Oncol; 1996 Dec; 23(6 Suppl 15):19-20. PubMed ID: 8996592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer.
    Socinski MA; Shea TC
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-45-S12-51. PubMed ID: 9331121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ; Meyers FJ; Houston J; Lauder I
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escalating paclitaxel doses combined with carboplatin/etoposide and thoracic radiotherapy as preoperative or definitive treatment for stage III non-small cell lung cancer.
    Bonomi P; Siddiqui S; Lincoln S; Sharma M; Recine D; Warren W; Faber LP
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):102-7. PubMed ID: 9007134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.